Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients
Not Applicable
Completed
- Conditions
- Tuberculosis
- Registration Number
- NCT01290081
- Lead Sponsor
- National Institute for Health Development, Estonia
- Brief Summary
The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
- Participation in substitution treatment program,
- Age 18 years or more,
- Able to read and write in Estonian or Russian,
- Able to provide informed consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
LLC Corrigo
🇪🇪Jõhvi, Ida-Virumaa, Estonia
LLC Corrigo🇪🇪Jõhvi, Ida-Virumaa, Estonia